U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
152161152161A Study of 2 Doses of MAP0010 and Placebo in Asthmatic ChildrenCompletedHas ResultsAsthmaDrug: 0.135mg MAP0010|Drug: 0.25mg MAP0010|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00569192
152162152162A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid MalignanciesTerminatedNo Results AvailableLeukemia, Myeloid, Acute|Leukemia, Lymphoid|Myelodysplastic Syndromes|Leukemia, Myelogenous, ChronicDevice: CliniMACS CD34 Reagent Systemhttps://ClinicalTrials.gov/show/NCT00569179
152163152163Three Different Programs of Paced Breathing in Treating Hot Flashes in WomenCompletedHas ResultsBreast Cancer|Fatigue|Hot Flashes|Sleep DisordersBehavioral: Paced breathing (15 min once daily, 6 breaths/min)|Behavioral: Paced breathing (15 min twice daily, 6 breaths/min)|Behavioral: Paced breathing (10 min once daily, 14 breaths/min)https://ClinicalTrials.gov/show/NCT00569166
152164152164Safety Study of TAK-700 in Subjects With Prostate Cancer.CompletedNo Results AvailableProstatic NeoplasmsDrug: TAK-700https://ClinicalTrials.gov/show/NCT00569153
152165152165A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular DegenerationCompletedNo Results AvailableAge-Related Macular DegenerationDrug: E10030https://ClinicalTrials.gov/show/NCT00569140
152166152166Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine TumorActive, not recruitingNo Results AvailableNeuroendocrine CarcinomaBiological: Recombinant Interferon Alfa-2b|Drug: Octreotide Acetate|Biological: Bevacizumabhttps://ClinicalTrials.gov/show/NCT00569127
152167152167Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) PatientsCompletedNo Results AvailableNon-small Cell Lung CancerDrug: TG01https://ClinicalTrials.gov/show/NCT00569114
152168152168A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus NephritisActive, not recruitingNo Results AvailableLupus NephritisDrug: tacrolimushttps://ClinicalTrials.gov/show/NCT00569101
152169152169Study of the Pathogenesis and Molecular Mechanism of "YURE" in Internal Intractable DiseasesRecruitingNo Results AvailableStrokeDrug: Chinese herbs formula|Drug: Mannitolhttps://ClinicalTrials.gov/show/NCT00569088
152170152170Apoptic Biomarkers of Periodontal DiseaseCompletedNo Results AvailablePeriodontitisOther: collection of gingival crevicular fluidhttps://ClinicalTrials.gov/show/NCT00569075
152171152171A Study of GW856553X For the Treatment of DepressionTerminatedNo Results AvailableDepressive Disorder, MajorDrug: GW856553X|Other: Placebohttps://ClinicalTrials.gov/show/NCT00569062
152172152172Molecular Analysis of Breast CancerActive, not recruitingNo Results AvailableBreast Cancer|Breast Cancer Non-invasive Breast Cancer|Breast Cancer Early Stage Breast Cancer (Stage 1-3)Procedure: breast tissue, lymph node tissue or bloodhttps://ClinicalTrials.gov/show/NCT00569049
152173152173Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid TumorsCompletedNo Results AvailableNeoplasms|Solid Tumors|MetastasesDrug: BMS-754807https://ClinicalTrials.gov/show/NCT00569036
152174152174Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta CaroteneCompletedNo Results AvailableNight BlindnessDietary Supplement: alga Dunaliella bardawilhttps://ClinicalTrials.gov/show/NCT00569023
152175152175Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)CompletedHas ResultsAcute Myelogenous Leukemia|Myelodysplastic Syndrome|LeukemiaDrug: Azacitidine|Drug: Ara-Chttps://ClinicalTrials.gov/show/NCT00569010
15217615217610 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used PimecrolimusRecruitingNo Results AvailableAtopic DermatitisDrug: Pimecrolimushttps://ClinicalTrials.gov/show/NCT00568997
152177152177Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: repaglinide|Drug: metformin|Drug: glicazidehttps://ClinicalTrials.gov/show/NCT00568984
152178152178Study of Weekly DCF to Treat Advanced Gastric CancerTerminatedNo Results AvailableGastric CancerDrug: Docetaxel, Cisplatin, 5-Fuhttps://ClinicalTrials.gov/show/NCT00568971
152179152179Naltrexone for Heavy Drinking in Young AdultsCompletedHas ResultsAlcohol Consumption|Alcoholic Intoxication|Alcoholism|Alcohol-induced DisordersBehavioral: BASICS counseling|Drug: naltrexone|Drug: placebo naltrexonehttps://ClinicalTrials.gov/show/NCT00568958
152180152180Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation.CompletedNo Results AvailableAtrial FibrillationDrug: Capadenoson (BAY68-4986)https://ClinicalTrials.gov/show/NCT00568945
152181152181Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung CarcinomaRecruitingNo Results AvailableCarcinoma, Giant Cell|Carcinoma, Non-Small-Cell Lung|Lung Cancerhttps://ClinicalTrials.gov/show/NCT00568906
152182152182An Open Label Study of Severe Sepsis in AdultsCompletedNo Results AvailableSevere SepsisDrug: drotrecogin alfa (activated)https://ClinicalTrials.gov/show/NCT00568893
152183152183Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple MyelomaRecruitingNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmDrug: bortezomib|Drug: hydroxychloroquine|Other: immunologic technique|Other: laboratory biomarker analysis|Other: mass spectrometry|Other: pharmacological study|Procedure: biopsyhttps://ClinicalTrials.gov/show/NCT00568880
152184152184Evaluation of Preexisting Immunity Markers in Human Tumor Tissue SampleCompletedNo Results AvailableCancerhttps://ClinicalTrials.gov/show/NCT00568867
152185152185Immunobiology of Diabetes and TuberculosisTerminatedNo Results AvailableTuberculosis|Diabetes MellitusBiological: BCGhttps://ClinicalTrials.gov/show/NCT00568854
152186152186Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)Active, not recruitingNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: erlotinib|Procedure: FDG-/FLT-PEThttps://ClinicalTrials.gov/show/NCT00568841
152187152187MPOD in Macular Teleangiectasia Following Supplementation of Lutein and ZeaxanthinRecruitingNo Results AvailableMacular Teleangiectasia|Macular Pigmenthttps://ClinicalTrials.gov/show/NCT00568828
152188152188Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL)CompletedNo Results AvailableLymphomaDrug: Rituximab combined with ESHAPhttps://ClinicalTrials.gov/show/NCT00568815
152189152189A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy PatientsActive, not recruitingNo Results AvailableMuscular Atrophy, SpinalDrug: Hydroxyureahttps://ClinicalTrials.gov/show/NCT00568802
152190152190Safety of Ramelteon in Elderly SubjectsCompletedNo Results AvailableInsomniaDrug: Ramelteon, zolpidem and placebohttps://ClinicalTrials.gov/show/NCT00568789

* Görseller ve İçerik tekif hakkına sahip olabilir